Search Constraints
Search Results
Select an image to start the slideshow
Loss of the Cortical Monoamine Projection Systems in the
MPTP-treated Nonhuman Primate Model of Parkinson's Disease
1 of 19
Optimized Delivery of C3 Transferase by Lentiviral Vectors forCNS Injury Therapy
2 of 19
RING FINGER PROTEIN 11 (RNF11) MEDIATES NF-κB SIGNALING AND
DOPAMINERGIC NEURODEGENERATION
3 of 19
Pesticides and Parkinson's disease: Attributable Risk of
Occupational Exposure and Neurochemical Analysis of Sub-Chronic
Environmental Exposure
4 of 19
Impaired vesicular storage of norepinephrine and serotonin in Parkinson's disease-related pathogenesis
5 of 19
Glutamatergic Inputs to the Monkey Subthalamic Nucleus: A
Comparison of Relative Abundance, Synaptology and Functional
Connectivity in Normal versus Parkinsonian Conditions.
6 of 19
Reduced vesicular storage of catecholamines in the pathogenesis of
Parkinson's Disease
7 of 19
Effects of Dopamine D1-Like Receptor Activation in the Internal Pallidal Segment and the Substantia Nigra Pars Reticulata of Normal and Parkinsonian Primates
8 of 19
Synaptic Vesicle Glycoprotein 2C (SV2C) in Parkinson's Disease-Related Striatal Vesicular Dysfunction
9 of 19
A role for the synaptic vesicle glycoprotein 2C (SV2C) in
dopamine homeostasis and Parkinson's disease
10 of 19
Ultrastructural Plasticity of Pallidothalamic GABAergic Terminals in Parkinson’s Disease: A 3D Electron Microscopy Study in the Parvocellular Ventral Anterior and Centromedian Thalamic Nuclei in MPTP-Treated Parkinsonian Monkeys
11 of 19
Abnormal muscle activity during balance before and after an exercise-based balance rehabilitation in people with Parkinson’s disease
12 of 19
Gene-Environment Interplay in Parkinson’s Disease Pathogenesis: The Role of Gastrointestinal Inflammation and Regulator of G-protein Signaling 10 in the Gut-Brain Axis
13 of 19
Innate and Adaptive Immune System Crosstalk in Parkinson's Disease
14 of 19
Cannabinoid type 2 receptors regulate striatal inflammation following alpha synuclein-induced nigral degeneration in rat model of Parkinson’s disease
15 of 19
The impact of LRRK2 expression and kinase activity in gene by environment mouse models of Parkinson’s disease
16 of 19
LRRK2 and Environmental Effects on Dopamine Systems within the Gut-Brain Axis: A Parkinson’s Disease Pathology Focus
17 of 19
The Effects of Chronic, Oral Deltamethrin Exposure on Nigrostriatal Dopamine Receptors: A Model for Pyrethroid Toxicity in Adults
18 of 19
Noradrenergic dysfunction in neurodegenerative disease
19 of 19